Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: A single-centre experience

Basit Öğe Kaydı
dc.authorid0000-0001-9975-5507
dc.authorid0000-0002-4607-5724
dc.authorid0000-0001-5825-8627
dc.authorid0000-0003-1919-3183
dc.authorid0000-0002-4281-0867
dc.authorid0000-0003-2995-8792
dc.authorid0000-0003-0230-6575
dc.contributor.authorDemir, Gültekin Günhan
dc.contributor.authorBabur Güler, Gamze
dc.contributor.authorGüler, Ekrem
dc.contributor.authorGüneş, Hacı Murat
dc.contributor.authorKızılırmak, Filiz
dc.contributor.authorKaraca, İbrahim Oğuz
dc.contributor.authorOmaygenç, Mehmet Onur
dc.contributor.authorÇakal, Beytullah
dc.contributor.authorOlgun, Erkam
dc.contributor.authorSavur, Umeyr
dc.contributor.authorİbişoğlu, Ersin
dc.contributor.authorBarutçu, İrfan
dc.contributor.authorKılıçaslan, Fethi
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:35:21Z
dc.date.available10.07.201910:49:14
dc.date.available2019-07-10T19:35:21Z
dc.date.issued2017
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı
dc.description.abstractObjective In modern cardiology practice, implantation of cardiac electronic devices in patients taking anticoagulant or antiplatelet therapy is a common clinical scenario. Bleeding complications are of particular concern in this patient population and pocket haematoma is one of the most frequent complications. We sought to determine the relationship between periprocedural antiplatelet/anticoagulant therapy and pocket haematoma formation in patients undergoing cardiac implantable electronic device (CIED) implantation. Methods We conducted a retrospective study including 232 consecutive patients undergoing CIED implantation in the department of cardiology of the Medipol University Hospital. Patients were divided into six groups: clopidogrel group (n = 12), acetylsalicylic acid (ASA) group (n = 73), ASA + clopidogrel group (n = 29), warfarin group (n = 34), warfarin + ASA group (n = 21) and no antiplatelet-anticoagulant therapy group as the control group (n = 63). CIED implantations were stratified under four subtitles including implantable cardioverter/defibrillator (ICD), cardiac resynchronization therapy (CRT), permanent pacemaker and the last group as either device upgrade or generator replacement. Results The mean age of the patients was 63 ± 14 years and 140 patients were male (60.3%). A pocket haematoma was documented in 6 of 232 patients (2.6%). None of the patients with pocket haematoma needed pocket exploration or blood transfusion. The type of the device did not have a significant effect on pocket haematoma incidence (P = 0.250). Univariate logistic regression showed that platelet level and ASA plus clopidogrel use were significantly associated with haematoma frequency after CIED implantations, respectively (OR: 0.977, CI 95% [0.958-0.996]; OR: 16.080, CI 95% [2.801-92.306]). Multivariate analysis revealed that dual antiplatelet treatment (ß = 3.016, P = 0.002, OR: 2.410, 95% CI [3.042-136.943]) and baseline platelet level (ß = –0.027, p:0.025, OR: 0.974, 95% CI [0.951-0.997]) were independent risk factors for pocket haematoma formation. Conclusion Dual antiplatelet therapy and low platelet levels significantly increased the risk of pocket haematoma formation in patients undergoing CIED implantations.
dc.identifier.citationDemir, G. G., Babur Güler, G., Güler, E., Güneş, H. M., Kızılırmak, F., Karaca, İ. O. ... Kılıçaslan, F. (2017). Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: A single-centre experience. Acta Cardiologica, 72(1), 47-52. https://dx.doi.org/10.1080/00015385.2017.1281539
dc.identifier.doi10.1080/00015385.2017.1281539
dc.identifier.endpage52
dc.identifier.issn0001-5385
dc.identifier.issn1784-973X
dc.identifier.issue1
dc.identifier.scopusqualityQ3
dc.identifier.startpage47
dc.identifier.urihttps://hdl.handle.net/20.500.12511/734
dc.identifier.urihttps://dx.doi.org/10.1080/00015385.2017.1281539
dc.identifier.volume72
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor and Francis
dc.relation.ispartofActa Cardiologicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCardiac Resynchronization Therapy
dc.subjectImplantable Cardioverter Defibrillator
dc.subjectPermanent Pacemaker
dc.subjectPocket Haematoma
dc.titlePocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: A single-centre experience
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Demir-Gunhan-2017.pdf
Boyut:
429.41 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu